Rank | Gene Set | Z-score |
---|---|---|
1 | * B cell receptor signaling pathway (GO:0050853) | 6.27510741 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.36126714 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.36126714 |
4 | modulation by symbiont of host immune response (GO:0052553) | 5.36126714 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.36126714 |
6 | modulation by symbiont of host defense response (GO:0052031) | 5.36126714 |
7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.36126714 |
8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.01118556 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97432301 |
10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.92441039 |
11 | detection of other organism (GO:0098543) | 4.87622971 |
12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.87467080 |
13 | detection of bacterium (GO:0016045) | 4.64703597 |
14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.45180794 |
15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.45180794 |
16 | * positive regulation of gamma-delta T cell activation (GO:0046645) | 4.39573641 |
17 | cellular response to zinc ion (GO:0071294) | 4.34051832 |
18 | immunoglobulin mediated immune response (GO:0016064) | 4.31495510 |
19 | respiratory burst (GO:0045730) | 4.30247074 |
20 | * regulation of B cell differentiation (GO:0045577) | 4.17711725 |
21 | * positive regulation of B cell differentiation (GO:0045579) | 4.16710402 |
22 | positive regulation of interferon-alpha production (GO:0032727) | 4.14289923 |
23 | detection of external biotic stimulus (GO:0098581) | 4.09148493 |
24 | regulation of interferon-alpha production (GO:0032647) | 3.93212961 |
25 | microglial cell activation (GO:0001774) | 3.92251919 |
26 | response to peptidoglycan (GO:0032494) | 3.88904963 |
27 | detection of molecule of bacterial origin (GO:0032490) | 3.81973621 |
28 | defense response to protozoan (GO:0042832) | 3.80991775 |
29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.78172112 |
30 | serine transport (GO:0032329) | 3.77992366 |
31 | * neutrophil activation (GO:0042119) | 3.77472195 |
32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.74094349 |
33 | negative regulation of phagocytosis (GO:0050765) | 3.72428741 |
34 | mature B cell differentiation (GO:0002335) | 3.66929484 |
35 | * granulocyte activation (GO:0036230) | 3.66671100 |
36 | B cell proliferation (GO:0042100) | 3.64770666 |
37 | * macrophage activation involved in immune response (GO:0002281) | 3.64439587 |
38 | detection of biotic stimulus (GO:0009595) | 3.63145090 |
39 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.59946418 |
40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.59673492 |
41 | negative regulation of cell killing (GO:0031342) | 3.59673492 |
42 | * regulation of mast cell degranulation (GO:0043304) | 3.56896157 |
43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.50068277 |
44 | germinal center formation (GO:0002467) | 3.49773734 |
45 | response to host immune response (GO:0052572) | 3.48418695 |
46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.48418695 |
47 | response to muramyl dipeptide (GO:0032495) | 3.47169200 |
48 | negative regulation of B cell proliferation (GO:0030889) | 3.45576125 |
49 | positive regulation of antigen processing and presentation (GO:0002579) | 3.44543117 |
50 | leukocyte aggregation (GO:0070486) | 3.43289435 |
51 | NIK/NF-kappaB signaling (GO:0038061) | 3.42268300 |
52 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.38782530 |
53 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.36737345 |
54 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.36343899 |
55 | response to protozoan (GO:0001562) | 3.34277417 |
56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.32912112 |
57 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.32892311 |
58 | negative thymic T cell selection (GO:0045060) | 3.31249731 |
59 | cellular extravasation (GO:0045123) | 3.30255120 |
60 | myeloid dendritic cell activation (GO:0001773) | 3.29904552 |
61 | B cell homeostasis (GO:0001782) | 3.29488002 |
62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29390472 |
63 | * regulation of mast cell activation (GO:0033003) | 3.27060053 |
64 | * regulation of leukocyte degranulation (GO:0043300) | 3.26897166 |
65 | * neutrophil activation involved in immune response (GO:0002283) | 3.26428231 |
66 | * regulation of mast cell activation involved in immune response (GO:0033006) | 3.26342846 |
67 | * macrophage activation (GO:0042116) | 3.25903265 |
68 | natural killer cell differentiation (GO:0001779) | 3.25320983 |
69 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.24128796 |
70 | natural killer cell mediated immunity (GO:0002228) | 3.24128796 |
71 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.23630104 |
72 | response to host (GO:0075136) | 3.23575376 |
73 | response to host defenses (GO:0052200) | 3.23575376 |
74 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23575376 |
75 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.23397767 |
76 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.18434229 |
77 | * regulation of gamma-delta T cell differentiation (GO:0045586) | 3.17655219 |
78 | B cell mediated immunity (GO:0019724) | 3.15666946 |
79 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.13637707 |
80 | positive thymic T cell selection (GO:0045059) | 3.13629879 |
81 | L-serine transport (GO:0015825) | 3.13406802 |
82 | myeloid dendritic cell differentiation (GO:0043011) | 3.12541021 |
83 | regulation of B cell proliferation (GO:0030888) | 3.11741943 |
84 | * positive regulation of mast cell activation (GO:0033005) | 3.11439868 |
85 | lymphocyte homeostasis (GO:0002260) | 3.10800589 |
86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10070077 |
87 | negative T cell selection (GO:0043383) | 3.09497247 |
88 | positive regulation of interferon-beta production (GO:0032728) | 3.09323012 |
89 | tolerance induction (GO:0002507) | 3.08249632 |
90 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07873824 |
91 | T cell homeostasis (GO:0043029) | 3.07179027 |
92 | regulation of histone H3-K9 methylation (GO:0051570) | 3.05456886 |
93 | * myeloid cell activation involved in immune response (GO:0002275) | 3.05370220 |
94 | negative regulation of bone resorption (GO:0045779) | 2.99923384 |
95 | leukocyte degranulation (GO:0043299) | 2.99881921 |
96 | positive T cell selection (GO:0043368) | 2.99182811 |
97 | response to type I interferon (GO:0034340) | 2.95384059 |
98 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.95351005 |
99 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.95313589 |
100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90710425 |
101 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.90701315 |
102 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.89154069 |
103 | T-helper 1 type immune response (GO:0042088) | 2.88827740 |
104 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.88768899 |
105 | type I interferon signaling pathway (GO:0060337) | 2.87777849 |
106 | cellular response to type I interferon (GO:0071357) | 2.87777849 |
107 | hepatocyte apoptotic process (GO:0097284) | 2.87086284 |
108 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.86850609 |
109 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.85923468 |
110 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.85923468 |
111 | T cell migration (GO:0072678) | 2.85858948 |
112 | I-kappaB phosphorylation (GO:0007252) | 2.85519703 |
113 | neutrophil mediated immunity (GO:0002446) | 2.85333224 |
114 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85306431 |
115 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.84972546 |
116 | positive regulation of type 2 immune response (GO:0002830) | 2.83568444 |
117 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83508847 |
118 | mononuclear cell proliferation (GO:0032943) | 2.83272103 |
119 | regulation of antigen processing and presentation (GO:0002577) | 2.83161599 |
120 | regulation of B cell apoptotic process (GO:0002902) | 2.81306755 |
121 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81147821 |
122 | positive regulation of granulocyte differentiation (GO:0030854) | 2.79221937 |
123 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.78328351 |
124 | lymphocyte proliferation (GO:0046651) | 2.77716160 |
125 | regulation of tolerance induction (GO:0002643) | 2.77189126 |
126 | negative regulation of innate immune response (GO:0045824) | 2.76989940 |
127 | negative regulation of interleukin-12 production (GO:0032695) | 2.76372604 |
128 | * myeloid leukocyte activation (GO:0002274) | 2.75677668 |
129 | negative regulation of interleukin-6 production (GO:0032715) | 2.75458297 |
130 | response to interleukin-15 (GO:0070672) | 2.74638024 |
131 | myeloid leukocyte mediated immunity (GO:0002444) | 2.74578985 |
132 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.74071309 |
133 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.73506093 |
134 | * regulation of gamma-delta T cell activation (GO:0046643) | 2.72716478 |
135 | adaptation of signaling pathway (GO:0023058) | 2.72338088 |
136 | leukocyte homeostasis (GO:0001776) | 2.72130084 |
137 | pinocytosis (GO:0006907) | 2.71694531 |
138 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.70999600 |
139 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.70942204 |
140 | mature B cell differentiation involved in immune response (GO:0002313) | 2.70280491 |
141 | B cell activation (GO:0042113) | 2.69407500 |
142 | positive regulation of B cell proliferation (GO:0030890) | 2.67012183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.11117675 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.94627383 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.26040263 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.95855991 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.67583329 |
6 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.57310944 |
7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.55089947 |
8 | * MYC_22102868_ChIP-Seq_BL_Human | 3.53072285 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.48897029 |
10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.41255103 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.38370786 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.34699179 |
13 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.20385792 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.99749084 |
15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.90854017 |
16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.58800360 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.57610430 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.57236125 |
19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.56946092 |
20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.51910331 |
21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.43533041 |
22 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.43136611 |
23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36272101 |
24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.32843692 |
25 | MAF_26560356_Chip-Seq_TH1_Human | 2.32202609 |
26 | MYB_26560356_Chip-Seq_TH2_Human | 2.27375369 |
27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.26040036 |
28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.25819320 |
29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24119874 |
30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22229182 |
31 | MYB_26560356_Chip-Seq_TH1_Human | 2.14932665 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10956404 |
33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10634709 |
34 | UTX_26944678_Chip-Seq_JUKART_Human | 2.08352648 |
35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07907967 |
36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.03621481 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 2.01205238 |
38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99777685 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97538761 |
40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.97386038 |
41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.96965755 |
42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81745534 |
43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80549399 |
44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75582889 |
45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71236700 |
46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70975568 |
47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.68257511 |
48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.68028147 |
49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.60886478 |
50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55145048 |
51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52866053 |
52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51958605 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51635424 |
54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48551406 |
55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45620197 |
56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41536036 |
57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40611622 |
58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35113688 |
59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34952891 |
60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33994275 |
61 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32731740 |
62 | MAF_26560356_Chip-Seq_TH2_Human | 1.31394244 |
63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31180512 |
64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27551657 |
65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27545315 |
66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26454834 |
67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24678520 |
68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24499883 |
69 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24444068 |
70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23791610 |
71 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22274759 |
72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22039140 |
73 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.20698010 |
74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15706337 |
75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10819245 |
76 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09701873 |
77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08262192 |
78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03859673 |
79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03583691 |
80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02139182 |
81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02113693 |
82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98316205 |
83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98044143 |
84 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96083837 |
85 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95402634 |
86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95383125 |
87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95366130 |
88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93849628 |
89 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92489206 |
90 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91854034 |
91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89663617 |
92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86818025 |
93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86448714 |
94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85716582 |
95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85145553 |
96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84740325 |
97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84646577 |
98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84041118 |
99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81328001 |
100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80106953 |
101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79977565 |
102 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.79462869 |
103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.79270658 |
104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79042838 |
105 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.77711209 |
106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77636670 |
107 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.77338527 |
108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.76265800 |
109 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75659519 |
110 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75325179 |
111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75060434 |
112 | P300_27268052_Chip-Seq_Bcells_Human | 0.74663343 |
113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.71355433 |
114 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70297048 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.75757670 |
2 | MP0003303_peritoneal_inflammation | 4.02989818 |
3 | MP0001800_abnormal_humoral_immune | 3.80562822 |
4 | MP0001790_abnormal_immune_system | 3.79445189 |
5 | MP0005387_immune_system_phenotype | 3.79445189 |
6 | MP0000685_abnormal_immune_system | 3.40514528 |
7 | MP0002452_abnormal_antigen_presenting | 3.28088401 |
8 | MP0003436_decreased_susceptibility_to | 3.09677659 |
9 | MP0005000_abnormal_immune_tolerance | 3.08293282 |
10 | MP0002723_abnormal_immune_serum | 2.81547167 |
11 | MP0009785_altered_susceptibility_to | 2.72451636 |
12 | MP0002420_abnormal_adaptive_immunity | 2.70302654 |
13 | MP0001819_abnormal_immune_cell | 2.67423803 |
14 | MP0002419_abnormal_innate_immunity | 2.64587966 |
15 | MP0005025_abnormal_response_to | 2.54180220 |
16 | MP0005671_abnormal_response_to | 2.51912413 |
17 | MP0002398_abnormal_bone_marrow | 2.43528034 |
18 | MP0002148_abnormal_hypersensitivity_rea | 2.40006019 |
19 | MP0000716_abnormal_immune_system | 2.27246417 |
20 | MP0000689_abnormal_spleen_morphology | 2.21157189 |
21 | MP0009278_abnormal_bone_marrow | 2.19903573 |
22 | MP0002166_altered_tumor_susceptibility | 2.10765775 |
23 | MP0002396_abnormal_hematopoietic_system | 2.04028266 |
24 | MP0004510_myositis | 2.03068909 |
25 | MP0005464_abnormal_platelet_physiology | 1.98054515 |
26 | MP0003300_gastrointestinal_ulcer | 1.96597832 |
27 | MP0002722_abnormal_immune_system | 1.93057657 |
28 | MP0002429_abnormal_blood_cell | 1.88530762 |
29 | MP0002405_respiratory_system_inflammati | 1.87335554 |
30 | MP0004947_skin_inflammation | 1.86112292 |
31 | MP0000569_abnormal_digit_pigmentation | 1.85862200 |
32 | MP0004808_abnormal_hematopoietic_stem | 1.83438595 |
33 | MP0005058_abnormal_lysosome_morphology | 1.81970277 |
34 | MP0001845_abnormal_inflammatory_respons | 1.75740230 |
35 | MP0006082_CNS_inflammation | 1.74855601 |
36 | MP0010155_abnormal_intestine_physiology | 1.73627724 |
37 | MP0002006_tumorigenesis | 1.73025970 |
38 | MP0001853_heart_inflammation | 1.66881751 |
39 | MP0006054_spinal_hemorrhage | 1.58393354 |
40 | MP0003183_abnormal_peptide_metabolism | 1.54456973 |
41 | MP0005451_abnormal_body_composition | 1.52493347 |
42 | MP0003172_abnormal_lysosome_physiology | 1.51515175 |
43 | MP0005397_hematopoietic_system_phenotyp | 1.48202527 |
44 | MP0001545_abnormal_hematopoietic_system | 1.48202527 |
45 | MP0002132_abnormal_respiratory_system | 1.47949378 |
46 | MP0001533_abnormal_skeleton_physiology | 1.43403945 |
47 | MP0000703_abnormal_thymus_morphology | 1.40285970 |
48 | MP0000465_gastrointestinal_hemorrhage | 1.37807007 |
49 | MP0005174_abnormal_tail_pigmentation | 1.30813691 |
50 | MP0003763_abnormal_thymus_physiology | 1.28827000 |
51 | MP0001873_stomach_inflammation | 1.28092663 |
52 | MP0003191_abnormal_cellular_cholesterol | 1.26392530 |
53 | MP0005310_abnormal_salivary_gland | 1.25885215 |
54 | MP0008469_abnormal_protein_level | 1.25872339 |
55 | MP0005076_abnormal_cell_differentiation | 1.25386725 |
56 | MP0005075_abnormal_melanosome_morpholog | 1.23844974 |
57 | MP0009333_abnormal_splenocyte_physiolog | 1.21147745 |
58 | MP0002933_joint_inflammation | 1.21139910 |
59 | MP0003724_increased_susceptibility_to | 1.20450731 |
60 | MP0004381_abnormal_hair_follicle | 1.15127534 |
61 | MP0003448_altered_tumor_morphology | 1.14276443 |
62 | MP0010307_abnormal_tumor_latency | 1.13568849 |
63 | MP0001879_abnormal_lymphatic_vessel | 1.10574589 |
64 | MP0003566_abnormal_cell_adhesion | 1.10498869 |
65 | MP0010352_gastrointestinal_tract_polyps | 1.10285282 |
66 | MP0004883_abnormal_blood_vessel | 1.09881760 |
67 | MP0008004_abnormal_stomach_pH | 1.06518604 |
68 | MP0002019_abnormal_tumor_incidence | 1.03020405 |
69 | MP0003866_abnormal_defecation | 1.00790735 |
70 | MP0000490_abnormal_crypts_of | 0.97237269 |
71 | MP0003690_abnormal_glial_cell | 0.95209510 |
72 | MP0003806_abnormal_nucleotide_metabolis | 0.95065023 |
73 | MP0002998_abnormal_bone_remodeling | 0.93784038 |
74 | MP0009840_abnormal_foam_cell | 0.90263096 |
75 | MP0001986_abnormal_taste_sensitivity | 0.90186907 |
76 | MP0009764_decreased_sensitivity_to | 0.89881846 |
77 | MP0003828_pulmonary_edema | 0.89396426 |
78 | MP0008057_abnormal_DNA_replication | 0.89043652 |
79 | MP0000015_abnormal_ear_pigmentation | 0.88122089 |
80 | MP0002009_preneoplasia | 0.86576843 |
81 | MP0000858_altered_metastatic_potential | 0.84827759 |
82 | MP0003091_abnormal_cell_migration | 0.84163290 |
83 | MP0000343_altered_response_to | 0.82138197 |
84 | MP0005166_decreased_susceptibility_to | 0.81393605 |
85 | MP0003075_altered_response_to | 0.79694660 |
86 | MP0002136_abnormal_kidney_physiology | 0.79324548 |
87 | MP0005164_abnormal_response_to | 0.77239596 |
88 | MP0001851_eye_inflammation | 0.77153256 |
89 | MP0000249_abnormal_blood_vessel | 0.74771643 |
90 | MP0003453_abnormal_keratinocyte_physiol | 0.74039950 |
91 | MP0010094_abnormal_chromosome_stability | 0.72493299 |
92 | MP0009763_increased_sensitivity_to | 0.71376178 |
93 | MP0002138_abnormal_hepatobiliary_system | 0.70868620 |
94 | MP0003077_abnormal_cell_cycle | 0.69963064 |
95 | MP0000604_amyloidosis | 0.69334986 |
96 | MP0003656_abnormal_erythrocyte_physiolo | 0.69209401 |
97 | MP0009765_abnormal_xenobiotic_induced | 0.66171688 |
98 | MP0002095_abnormal_skin_pigmentation | 0.66103015 |
99 | MP0000767_abnormal_smooth_muscle | 0.64808120 |
100 | MP0005621_abnormal_cell_physiology | 0.64115776 |
101 | MP0000371_diluted_coat_color | 0.62405517 |
102 | MP0001663_abnormal_digestive_system | 0.62378513 |
103 | MP0003279_aneurysm | 0.61687554 |
104 | MP0002277_abnormal_respiratory_mucosa | 0.61474495 |
105 | MP0001915_intracranial_hemorrhage | 0.60242732 |
106 | MP0003795_abnormal_bone_structure | 0.59815363 |
107 | MP0008260_abnormal_autophagy | 0.59473158 |
108 | MP0002928_abnormal_bile_duct | 0.56882571 |
109 | MP0003045_fibrosis | 0.56304647 |
110 | MP0000313_abnormal_cell_death | 0.55817444 |
111 | MP0008874_decreased_physiological_sensi | 0.54430032 |
112 | MP0005390_skeleton_phenotype | 0.54095849 |
113 | MP0005023_abnormal_wound_healing | 0.54008917 |
114 | MP0005319_abnormal_enzyme/_coenzyme | 0.53890986 |
115 | MP0001958_emphysema | 0.53733426 |
116 | MP0000609_abnormal_liver_physiology | 0.51745862 |
117 | MP0009115_abnormal_fat_cell | 0.51537869 |
118 | MP0009931_abnormal_skin_appearance | 0.51204214 |
119 | MP0005381_digestive/alimentary_phenotyp | 0.47498985 |
120 | MP0004130_abnormal_muscle_cell | 0.44642097 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Agammaglobulinemia (HP:0004432) | 6.72090193 |
2 | Cellulitis (HP:0100658) | 6.23011781 |
3 | Recurrent abscess formation (HP:0002722) | 5.53348553 |
4 | Recurrent bacterial skin infections (HP:0005406) | 5.22191321 |
5 | Recurrent viral infections (HP:0004429) | 5.10156844 |
6 | Papilloma (HP:0012740) | 4.93212078 |
7 | Verrucae (HP:0200043) | 4.93212078 |
8 | Colitis (HP:0002583) | 4.78468918 |
9 | Eczematoid dermatitis (HP:0000976) | 4.50882475 |
10 | Abnormality of B cell number (HP:0010975) | 4.48129434 |
11 | B lymphocytopenia (HP:0010976) | 4.48129434 |
12 | Recurrent bronchitis (HP:0002837) | 4.46006653 |
13 | Meningitis (HP:0001287) | 4.45107885 |
14 | Gastrointestinal stroma tumor (HP:0100723) | 4.30992419 |
15 | Recurrent fungal infections (HP:0002841) | 4.25031485 |
16 | Osteomyelitis (HP:0002754) | 4.14415876 |
17 | Thyroiditis (HP:0100646) | 4.12547192 |
18 | Inflammation of the large intestine (HP:0002037) | 4.11581008 |
19 | Panhypogammaglobulinemia (HP:0003139) | 4.03864472 |
20 | Gastrointestinal inflammation (HP:0004386) | 3.96397000 |
21 | Mediastinal lymphadenopathy (HP:0100721) | 3.88626984 |
22 | Recurrent sinusitis (HP:0011108) | 3.75463174 |
23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.74218023 |
24 | Small epiphyses (HP:0010585) | 3.55162511 |
25 | Recurrent skin infections (HP:0001581) | 3.51695212 |
26 | Recurrent pneumonia (HP:0006532) | 3.48691883 |
27 | Encephalitis (HP:0002383) | 3.48470452 |
28 | IgM deficiency (HP:0002850) | 3.45210391 |
29 | Sepsis (HP:0100806) | 3.44032346 |
30 | Vasculitis (HP:0002633) | 3.36898479 |
31 | Abnormality of glycolipid metabolism (HP:0010969) | 3.29561747 |
32 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.29561747 |
33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.29561747 |
34 | Chronic otitis media (HP:0000389) | 3.27698678 |
35 | Chronic sinusitis (HP:0011109) | 3.22389227 |
36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.18019891 |
37 | Gastrointestinal infarctions (HP:0005244) | 3.15056313 |
38 | Abnormality of macrophages (HP:0004311) | 3.13180250 |
39 | Recurrent lower respiratory tract infections (HP:0002783) | 3.09320386 |
40 | Lymphopenia (HP:0001888) | 3.06558241 |
41 | Obstructive lung disease (HP:0006536) | 3.04889116 |
42 | Chronic obstructive pulmonary disease (HP:0006510) | 3.04889116 |
43 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.01145340 |
44 | Recurrent cutaneous fungal infections (HP:0011370) | 3.01145340 |
45 | Epistaxis (HP:0000421) | 2.99908910 |
46 | Autoimmune thrombocytopenia (HP:0001973) | 2.98651689 |
47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.97811100 |
48 | Chest pain (HP:0100749) | 2.95341421 |
49 | Emphysema (HP:0002097) | 2.94099234 |
50 | Mitral stenosis (HP:0001718) | 2.92448054 |
51 | Keratoconjunctivitis sicca (HP:0001097) | 2.88760766 |
52 | Hemoptysis (HP:0002105) | 2.86207351 |
53 | Periodontitis (HP:0000704) | 2.71576519 |
54 | Restrictive lung disease (HP:0002091) | 2.69661821 |
55 | Gingivitis (HP:0000230) | 2.69318770 |
56 | T lymphocytopenia (HP:0005403) | 2.67669444 |
57 | Keratoconjunctivitis (HP:0001096) | 2.66531460 |
58 | Eosinophilia (HP:0001880) | 2.66410889 |
59 | Abnormality of T cell number (HP:0011839) | 2.62844385 |
60 | Pustule (HP:0200039) | 2.60712786 |
61 | Hematochezia (HP:0002573) | 2.60045862 |
62 | Abnormality of the fingertips (HP:0001211) | 2.58841310 |
63 | Purpura (HP:0000979) | 2.51650474 |
64 | Myositis (HP:0100614) | 2.51183096 |
65 | Severe combined immunodeficiency (HP:0004430) | 2.50473465 |
66 | Combined immunodeficiency (HP:0005387) | 2.49763191 |
67 | Vertebral arch anomaly (HP:0008438) | 2.48035145 |
68 | Interstitial pulmonary disease (HP:0006530) | 2.46942116 |
69 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.46519771 |
70 | Pulmonary embolism (HP:0002204) | 2.44577560 |
71 | Abnormality of the prostate (HP:0008775) | 2.44220714 |
72 | Spontaneous hematomas (HP:0007420) | 2.42743241 |
73 | Amyloidosis (HP:0011034) | 2.42129739 |
74 | Recurrent otitis media (HP:0000403) | 2.40650380 |
75 | Leukocytosis (HP:0001974) | 2.39725581 |
76 | Flattened epiphyses (HP:0003071) | 2.39281532 |
77 | Hypoplasia of the thymus (HP:0000778) | 2.38813072 |
78 | Dysostosis multiplex (HP:0000943) | 2.37859050 |
79 | Bronchitis (HP:0012387) | 2.37681273 |
80 | Loss of speech (HP:0002371) | 2.36105705 |
81 | IgG deficiency (HP:0004315) | 2.35467295 |
82 | Abnormality of T cells (HP:0002843) | 2.30919172 |
83 | Increased cerebral lipofuscin (HP:0011813) | 2.30437493 |
84 | Skin ulcer (HP:0200042) | 2.30374677 |
85 | Ulnar bowing (HP:0003031) | 2.30089736 |
86 | Granulocytopenia (HP:0001913) | 2.27626195 |
87 | Abnormality of the intervertebral disk (HP:0005108) | 2.24939591 |
88 | Stomatitis (HP:0010280) | 2.22614686 |
89 | Abnormality of the pleura (HP:0002103) | 2.20741256 |
90 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.19661905 |
91 | IgA deficiency (HP:0002720) | 2.18451635 |
92 | Vacuolated lymphocytes (HP:0001922) | 2.18385602 |
93 | Hepatosplenomegaly (HP:0001433) | 2.17712721 |
94 | Abnormality of eosinophils (HP:0001879) | 2.16250463 |
95 | Episodic fever (HP:0001954) | 2.14539871 |
96 | Increased serum ferritin (HP:0003281) | 2.14224340 |
97 | Anorexia (HP:0002039) | 2.14129861 |
98 | Pulmonary infiltrates (HP:0002113) | 2.11480165 |
99 | Gangrene (HP:0100758) | 2.09558864 |
100 | Skin rash (HP:0000988) | 2.09445623 |
101 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.09028643 |
102 | Leukopenia (HP:0001882) | 2.08534333 |
103 | Increased IgE level (HP:0003212) | 2.08226035 |
104 | Hypergammaglobulinemia (HP:0010702) | 2.07992524 |
105 | Urticaria (HP:0001025) | 2.05147108 |
106 | Autoimmune hemolytic anemia (HP:0001890) | 2.04995081 |
107 | Thrombocytosis (HP:0001894) | 2.04393878 |
108 | Lymphoma (HP:0002665) | 2.04221442 |
109 | Abnormality of the peritoneum (HP:0002585) | 2.03211123 |
110 | Systemic lupus erythematosus (HP:0002725) | 2.02456602 |
111 | Abnormality of iron homeostasis (HP:0011031) | 2.01589083 |
112 | Nasal polyposis (HP:0100582) | 2.01299916 |
113 | Increased IgM level (HP:0003496) | 1.98413184 |
114 | Abnormality of T cell physiology (HP:0011840) | 1.98398254 |
115 | Prolonged bleeding time (HP:0003010) | 1.97726126 |
116 | Amaurosis fugax (HP:0100576) | 1.96337556 |
117 | Orchitis (HP:0100796) | 1.92873823 |
118 | Arterial thrombosis (HP:0004420) | 1.92464881 |
119 | Viral hepatitis (HP:0006562) | 1.91591143 |
120 | Arthropathy (HP:0003040) | 1.91362275 |
121 | Disinhibition (HP:0000734) | 1.90021351 |
122 | Retrobulbar optic neuritis (HP:0100654) | 1.88332057 |
123 | Optic neuritis (HP:0100653) | 1.88332057 |
124 | Petechiae (HP:0000967) | 1.88303119 |
125 | Neutropenia (HP:0001875) | 1.88088630 |
126 | Myocardial infarction (HP:0001658) | 1.86382732 |
127 | Gingival bleeding (HP:0000225) | 1.84700186 |
128 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84466207 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K10 | 5.88665527 |
2 | MAP4K1 | 4.50683151 |
3 | RIPK4 | 3.64624634 |
4 | ERN1 | 3.40610368 |
5 | BLK | 3.29101883 |
6 | GRK6 | 3.15194733 |
7 | MAP3K14 | 2.54446066 |
8 | CSF1R | 2.41301599 |
9 | TYK2 | 2.40116453 |
10 | PRPF4B | 2.34481460 |
11 | BTK | 2.14948360 |
12 | TBK1 | 2.12622332 |
13 | STK10 | 1.98141965 |
14 | IRAK4 | 1.91801084 |
15 | * SYK | 1.83946230 |
16 | SIK2 | 1.78311053 |
17 | BMPR2 | 1.64568416 |
18 | KIT | 1.63352284 |
19 | IRAK3 | 1.62922996 |
20 | JAK1 | 1.62393688 |
21 | CDK12 | 1.61125260 |
22 | EEF2K | 1.59622446 |
23 | MAP3K13 | 1.58601090 |
24 | CSK | 1.55550723 |
25 | IKBKB | 1.50943438 |
26 | LRRK2 | 1.50583236 |
27 | HCK | 1.48760311 |
28 | FES | 1.47737134 |
29 | TRIB3 | 1.46804081 |
30 | STK4 | 1.46586963 |
31 | PIM1 | 1.44383298 |
32 | MAP3K3 | 1.37593713 |
33 | IKBKE | 1.33414171 |
34 | * LYN | 1.32495933 |
35 | TGFBR2 | 1.32017934 |
36 | JAK3 | 1.29855032 |
37 | MAP3K11 | 1.28363765 |
38 | CLK1 | 1.24252633 |
39 | ZAP70 | 1.21171352 |
40 | PIK3CG | 1.17861296 |
41 | MATK | 1.15122931 |
42 | PKN2 | 1.13666941 |
43 | MARK3 | 1.12967655 |
44 | MAP3K1 | 1.11989593 |
45 | CDK4 | 1.07272084 |
46 | TESK2 | 1.07214748 |
47 | TAOK1 | 1.06460713 |
48 | TLK1 | 0.94860073 |
49 | * LCK | 0.91372244 |
50 | IRAK1 | 0.91221484 |
51 | NEK2 | 0.90956048 |
52 | TEC | 0.88662806 |
53 | CHUK | 0.86398380 |
54 | SMG1 | 0.86258254 |
55 | IRAK2 | 0.83021196 |
56 | MAP2K3 | 0.82945664 |
57 | TAOK3 | 0.82517617 |
58 | FGFR3 | 0.80850214 |
59 | PDPK1 | 0.80777341 |
60 | FGR | 0.77828189 |
61 | EPHB1 | 0.77644978 |
62 | ITK | 0.77385982 |
63 | CDK9 | 0.76913360 |
64 | RPS6KA4 | 0.76789827 |
65 | CAMK1D | 0.74954838 |
66 | DYRK1B | 0.71238552 |
67 | GRK7 | 0.71175256 |
68 | MAPK4 | 0.70983855 |
69 | TTN | 0.69979628 |
70 | PTK6 | 0.69293918 |
71 | SIK3 | 0.67925250 |
72 | JAK2 | 0.67395845 |
73 | CDK6 | 0.64937590 |
74 | KSR2 | 0.64774090 |
75 | MARK2 | 0.61407401 |
76 | MAPK7 | 0.59759939 |
77 | MAP3K2 | 0.59669265 |
78 | TAOK2 | 0.59603467 |
79 | BRD4 | 0.58019261 |
80 | CAMK1G | 0.57971228 |
81 | HIPK2 | 0.55618210 |
82 | ABL1 | 0.55321343 |
83 | CDC42BPA | 0.54691507 |
84 | TNK2 | 0.52838192 |
85 | RPS6KL1 | 0.52005938 |
86 | EIF2AK3 | 0.50662609 |
87 | MAP3K8 | 0.50162848 |
88 | MAP3K6 | 0.49598525 |
89 | ACVR1B | 0.49058797 |
90 | ALK | 0.48583313 |
91 | STK3 | 0.47033143 |
92 | CDK19 | 0.46132965 |
93 | SIK1 | 0.45881174 |
94 | MST4 | 0.45034906 |
95 | MAP3K5 | 0.45023595 |
96 | PRKCQ | 0.44994702 |
97 | TRPM7 | 0.43952422 |
98 | MAPK12 | 0.43802205 |
99 | STK24 | 0.43729017 |
100 | WNK1 | 0.42217219 |
101 | MAP2K2 | 0.42113343 |
102 | MELK | 0.41693190 |
103 | PDK1 | 0.40766174 |
104 | BMX | 0.40577000 |
105 | PRKCD | 0.40256055 |
106 | MAPK11 | 0.38999407 |
107 | SCYL2 | 0.38001689 |
108 | YES1 | 0.37448052 |
109 | RPS6KB2 | 0.35572626 |
110 | MAP2K6 | 0.34636051 |
111 | MAPKAPK2 | 0.34252548 |
112 | FGFR4 | 0.32115088 |
113 | NME2 | 0.31351850 |
114 | MAP3K7 | 0.30261333 |
115 | * EGFR | 0.29874261 |
116 | * FYN | 0.29566125 |
117 | TXK | 0.28390757 |
118 | RPS6KA6 | 0.28145557 |
119 | MAP2K1 | 0.28133186 |
120 | SGK3 | 0.27739588 |
121 | CAMKK2 | 0.26835151 |
122 | RET | 0.26762732 |
123 | STK11 | 0.26230239 |
124 | NEK9 | 0.26001236 |
125 | MAPK3 | 0.25623382 |
126 | PRKD2 | 0.25443969 |
127 | RAF1 | 0.25438068 |
128 | RPS6KA5 | 0.24914160 |
129 | PKN1 | 0.24215474 |
130 | RPS6KC1 | 0.20198934 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.22106543 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.81533995 |
3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.97987493 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.93991751 |
5 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.61751900 |
6 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.54212254 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.19814013 |
8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.19413425 |
9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.11294193 |
10 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.09550381 |
11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.95415800 |
12 | Measles_Homo sapiens_hsa05162 | 1.89142782 |
13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87499696 |
14 | * Tuberculosis_Homo sapiens_hsa05152 | 1.86565741 |
15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.78044284 |
16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76223942 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69080015 |
18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.67385090 |
19 | Pertussis_Homo sapiens_hsa05133 | 1.65549147 |
20 | Influenza A_Homo sapiens_hsa05164 | 1.56848230 |
21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56402348 |
22 | Legionellosis_Homo sapiens_hsa05134 | 1.55806042 |
23 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.55746648 |
24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54695528 |
25 | Malaria_Homo sapiens_hsa05144 | 1.54410773 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51591885 |
27 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43943659 |
28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41224296 |
29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.40537871 |
30 | Apoptosis_Homo sapiens_hsa04210 | 1.40204629 |
31 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.39439590 |
32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37329167 |
33 | Shigellosis_Homo sapiens_hsa05131 | 1.34525838 |
34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32216341 |
35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31907330 |
36 | Hepatitis B_Homo sapiens_hsa05161 | 1.31754403 |
37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31749906 |
38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22358764 |
39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20501276 |
40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.19015033 |
41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18622313 |
42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15996319 |
43 | Lysosome_Homo sapiens_hsa04142 | 1.14714086 |
44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14275626 |
45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12518894 |
46 | Salmonella infection_Homo sapiens_hsa05132 | 1.12435129 |
47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12082674 |
48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09134818 |
49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06748453 |
50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04238480 |
51 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 1.04162297 |
52 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03727553 |
53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02439449 |
54 | Allograft rejection_Homo sapiens_hsa05330 | 0.99606118 |
55 | * Platelet activation_Homo sapiens_hsa04611 | 0.98389003 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 0.93868455 |
57 | Base excision repair_Homo sapiens_hsa03410 | 0.92811112 |
58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.91283622 |
59 | Asthma_Homo sapiens_hsa05310 | 0.84930779 |
60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84902538 |
61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84769480 |
62 | Phagosome_Homo sapiens_hsa04145 | 0.79400312 |
63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78335760 |
64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75919440 |
65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72452903 |
66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71065925 |
67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69778213 |
68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67936126 |
69 | Insulin resistance_Homo sapiens_hsa04931 | 0.67793821 |
70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64912493 |
71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64604241 |
72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63416260 |
73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60315102 |
74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60104614 |
75 | Glioma_Homo sapiens_hsa05214 | 0.57910976 |
76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57296721 |
77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56866483 |
78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55069245 |
79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53569534 |
80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53519811 |
81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51713828 |
82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50793128 |
83 | Amoebiasis_Homo sapiens_hsa05146 | 0.48848018 |
84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48351118 |
85 | Endocytosis_Homo sapiens_hsa04144 | 0.48013138 |
86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46484815 |
87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46069834 |
88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45985140 |
89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45578185 |
90 | DNA replication_Homo sapiens_hsa03030 | 0.45133849 |
91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44356380 |
92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44158472 |
93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43875735 |
94 | Prostate cancer_Homo sapiens_hsa05215 | 0.43738633 |
95 | Lysine degradation_Homo sapiens_hsa00310 | 0.43389008 |
96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42448790 |
97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42309488 |
98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40786637 |
99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39888925 |
100 | Alcoholism_Homo sapiens_hsa05034 | 0.39881303 |
101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39625722 |
102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38103546 |
103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36920912 |
104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36732159 |
105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36542640 |
106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.34940922 |
107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34729942 |
108 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34469292 |
109 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34346729 |
110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33631404 |
111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30027026 |
112 | Mismatch repair_Homo sapiens_hsa03430 | 0.29379964 |
113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27156220 |
114 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.27048519 |
115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26750516 |
116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.21371372 |
117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20166371 |
118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19896323 |